NovoCure Ltd Quarterly Current Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
NovoCure Ltd quarterly Current Ratio history and growth rate from Q2 2016 to Q3 2024.
  • NovoCure Ltd Current Ratio for the quarter ending September 30, 2024 was 340 %, a 51.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 340 -362 -51.6% Sep 30, 2024
Q2 2024 628 -102 -14% Jun 30, 2024
Q1 2024 642 -111 -14.7% Mar 31, 2024
Q4 2023 667 -112 -14.4% Dec 31, 2023
Q3 2023 702 -93.9 -11.8% Sep 30, 2023
Q2 2023 730 -84.5 -10.4% Jun 30, 2023
Q1 2023 753 -82.2 -9.84% Mar 31, 2023
Q4 2022 780 -71.6 -8.42% Dec 31, 2022
Q3 2022 796 -92.7 -10.4% Sep 30, 2022
Q2 2022 814 +23.6 +2.99% Jun 30, 2022
Q1 2022 835 +122 +17.1% Mar 31, 2022
Q4 2021 851 +234 +38% Dec 31, 2021
Q3 2021 888 +383 +75.8% Sep 30, 2021
Q2 2021 791 +256 +47.8% Jun 30, 2021
Q1 2021 713 +196 +37.9% Mar 31, 2021
Q4 2020 617 +118 +23.6% Dec 31, 2020
Q3 2020 505 +9.92 +2% Sep 30, 2020
Q2 2020 535 +19.9 +3.87% Jun 30, 2020
Q1 2020 517 -26.1 -4.79% Mar 31, 2020
Q4 2019 499 -88.8 -15.1% Dec 31, 2019
Q3 2019 495 -96.6 -16.3% Sep 30, 2019
Q2 2019 515 -70.1 -12% Jun 30, 2019
Q1 2019 544 -44.6 -7.59% Mar 31, 2019
Q4 2018 588 -23.3 -3.81% Dec 31, 2018
Q3 2018 592 -86.7 -12.8% Sep 30, 2018
Q2 2018 585 -173 -22.8% Jun 30, 2018
Q1 2018 588 -172 -22.6% Mar 31, 2018
Q4 2017 611 -179 -22.6% Dec 31, 2017
Q3 2017 679 -190 -21.9% Sep 30, 2017
Q2 2017 758 -44 -5.49% Jun 30, 2017
Q1 2017 760 Mar 31, 2017
Q4 2016 790 Dec 31, 2016
Q3 2016 869 Sep 30, 2016
Q2 2016 802 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.